Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Dendritic cells (DC) are one of the major antigen presenting cells found in lymphoid organs. The main functions of dendritic cells are antigen display and activation of T cells. Antigen display presents the characteristics of the pathogen to T cells for identification and elimination from the body. These cells have the ability to capture and process tumor antigens that activate the expression of lymphocyte costimulatory molecules. Therefore, it causes secretion of cytokines to elicit an immune response.
This report elaborates on the current development of the Dendritic Cell Cancer Vaccine industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
DanDrit Biotech
DCPrime
Bellicum Pharmaceuticals
Medigene
Argos Therapeutics
Sanpower Corporation (Dendreon)
Vaxil Bio
Elios Therapeutics
Tella
Batavia Bioservices
Kiromic
Northwest Biotherapeutics
Immunicum
Creagene
Activarti
By Type:
Provenge
Tumor Antigen Presenting Cells
CreaVax
By Application:
Adults
Pediatrics
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Dendritic Cell Cancer Vaccine Market Overview 2018-2029
-
1.1 China Dendritic Cell Cancer Vaccine Industry Development Overview
-
1.2 China Dendritic Cell Cancer Vaccine Industry Development History
-
1.3 China Dendritic Cell Cancer Vaccine Industry Market Size (2018-2029)
-
1.4 China Dendritic Cell Cancer Vaccine Market Analysis by Type from Production Side
-
1.4.1 China Dendritic Cell Cancer Vaccine Production Volume, Production Value and Growth Rate of Provenge (2018-2029)
-
1.4.2 China Dendritic Cell Cancer Vaccine Production Volume, Production Value and Growth Rate of Tumor Antigen Presenting Cells (2018-2029)
-
1.4.3 China Dendritic Cell Cancer Vaccine Production Volume, Production Value and Growth Rate of CreaVax (2018-2029)
-
1.5 China Dendritic Cell Cancer Vaccine Market Analysis by Application from Consumption End
-
1.5.1 China Dendritic Cell Cancer Vaccine Sales Volume, Sales Value and Growth Rate of Adults (2018-2029)
-
1.5.2 China Dendritic Cell Cancer Vaccine Sales Volume, Sales Value and Growth Rate of Pediatrics (2018-2029)
-
1.6 China Dendritic Cell Cancer Vaccine Market Analysis by Region
-
1.6.1 North China Dendritic Cell Cancer Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Dendritic Cell Cancer Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Dendritic Cell Cancer Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Dendritic Cell Cancer Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Dendritic Cell Cancer Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Dendritic Cell Cancer Vaccine Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Dendritic Cell Cancer Vaccine Market Size and Growth Rate from 2018-2029
Chapter 2 China Dendritic Cell Cancer Vaccine Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Dendritic Cell Cancer Vaccine Market Status and Competition at home and abroad in 2023
-
2.2.2 China Dendritic Cell Cancer Vaccine Market Status and Competition Analysis in 2023
-
2.2.3 China Dendritic Cell Cancer Vaccine Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Dendritic Cell Cancer Vaccine Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Dendritic Cell Cancer Vaccine Industry Development
Chapter 3 Dendritic Cell Cancer VaccineIndustry Chain Analysis
-
3.1 Dendritic Cell Cancer Vaccine Industry Chain
-
3.2 Dendritic Cell Cancer Vaccine Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Dendritic Cell Cancer Vaccine Market
-
3.3 Dendritic Cell Cancer Vaccine Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Dendritic Cell Cancer Vaccine Market
Chapter 4 China Dendritic Cell Cancer Vaccine Market, by Type
-
4.1 China Dendritic Cell Cancer Vaccine Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Dendritic Cell Cancer Vaccine Total Production Volume and Growth Rate from Production Side
-
4.5 China Dendritic Cell Cancer Vaccine Production Volume and Growth Rate, by Type
-
4.5.1 China Dendritic Cell Cancer Vaccine Production Volume and Growth Rate of Provenge
-
4.5.2 China Dendritic Cell Cancer Vaccine Production Volume and Growth Rate of Tumor Antigen Presenting Cells
-
4.5.3 China Dendritic Cell Cancer Vaccine Production Volume and Growth Rate of CreaVax
Chapter 5 China Dendritic Cell Cancer Vaccine Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Dendritic Cell Cancer Vaccine Total Market Size and Growth Rate from Consumption End
-
5.5 China Dendritic Cell Cancer Vaccine Market Size and Growth Rate, by Application
-
5.5.1 China Dendritic Cell Cancer Vaccine Market Size and Growth Rate of Adults
-
5.5.2 China Dendritic Cell Cancer Vaccine Market Size and Growth Rate of Pediatrics
Chapter 6 China Dendritic Cell Cancer Vaccine Market, by Region
-
6.1 China Dendritic Cell Cancer Vaccine Production Volume and Production Value, by Region
-
6.2 China Dendritic Cell Cancer Vaccine Sales Volume and Sales Value, by Region
Chapter 7 North China Dendritic Cell Cancer Vaccine Market Analysis
-
7.1 North China Dendritic Cell Cancer Vaccine Market, by Type
-
7.2 North China Dendritic Cell Cancer Vaccine Market, by Application
Chapter 8 Central China Dendritic Cell Cancer Vaccine Market Analysis
-
8.1 Central China Dendritic Cell Cancer Vaccine Market, by Type
-
8.2 Central China Dendritic Cell Cancer Vaccine Market, by Application
Chapter 9 South China Dendritic Cell Cancer Vaccine Market Analysis
-
9.1 South China Dendritic Cell Cancer Vaccine Market, by Type
-
9.2 South China Dendritic Cell Cancer Vaccine Market, by Application
Chapter 10 East China Dendritic Cell Cancer Vaccine Market Analysis
-
10.1 East China Dendritic Cell Cancer Vaccine Market, by Type
-
10.2 East China Dendritic Cell Cancer Vaccine Market, by Application
Chapter 11 Northeast China Dendritic Cell Cancer Vaccine Market Analysis
-
11.1 Northeast China Dendritic Cell Cancer Vaccine Market, by Type
-
11.2 Northeast China Dendritic Cell Cancer Vaccine Market, by Application
Chapter 12 Southwest China Dendritic Cell Cancer Vaccine Market Analysis
-
12.1 Southwest China Dendritic Cell Cancer Vaccine Market, by Type
-
12.2 Southwest China Dendritic Cell Cancer Vaccine Market, by Application
Chapter 13 Northwest China Dendritic Cell Cancer Vaccine Market Analysis
-
13.1 Northwest China Dendritic Cell Cancer Vaccine Market, by Type
-
13.2 Northwest China Dendritic Cell Cancer Vaccine Market, by Application
Chapter 14 Company Profiles
-
14.1 DanDrit Biotech
-
14.1.1 DanDrit Biotech Company Profile
-
14.1.2 DanDrit Biotech Dendritic Cell Cancer Vaccine Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 DCPrime
-
14.2.1 DCPrime Company Profile
-
14.2.2 DCPrime Dendritic Cell Cancer Vaccine Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Bellicum Pharmaceuticals
-
14.3.1 Bellicum Pharmaceuticals Company Profile
-
14.3.2 Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Medigene
-
14.4.1 Medigene Company Profile
-
14.4.2 Medigene Dendritic Cell Cancer Vaccine Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Argos Therapeutics
-
14.5.1 Argos Therapeutics Company Profile
-
14.5.2 Argos Therapeutics Dendritic Cell Cancer Vaccine Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Sanpower Corporation (Dendreon)
-
14.6.1 Sanpower Corporation (Dendreon) Company Profile
-
14.6.2 Sanpower Corporation (Dendreon) Dendritic Cell Cancer Vaccine Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Vaxil Bio
-
14.7.1 Vaxil Bio Company Profile
-
14.7.2 Vaxil Bio Dendritic Cell Cancer Vaccine Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Elios Therapeutics
-
14.8.1 Elios Therapeutics Company Profile
-
14.8.2 Elios Therapeutics Dendritic Cell Cancer Vaccine Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Tella
-
14.9.1 Tella Company Profile
-
14.9.2 Tella Dendritic Cell Cancer Vaccine Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Batavia Bioservices
-
14.10.1 Batavia Bioservices Company Profile
-
14.10.2 Batavia Bioservices Dendritic Cell Cancer Vaccine Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Kiromic
-
14.11.1 Kiromic Company Profile
-
14.11.2 Kiromic Dendritic Cell Cancer Vaccine Market Performance
-
14.11.3 Product&Service Introduction
-
14.12 Northwest Biotherapeutics
-
14.12.1 Northwest Biotherapeutics Company Profile
-
14.12.2 Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Market Performance
-
14.12.3 Product&Service Introduction
-
14.13 Immunicum
-
14.13.1 Immunicum Company Profile
-
14.13.2 Immunicum Dendritic Cell Cancer Vaccine Market Performance
-
14.13.3 Product&Service Introduction
-
14.14 Creagene
-
14.14.1 Creagene Company Profile
-
14.14.2 Creagene Dendritic Cell Cancer Vaccine Market Performance
-
14.14.3 Product&Service Introduction
-
14.15 Activarti
-
14.15.1 Activarti Company Profile
-
14.15.2 Activarti Dendritic Cell Cancer Vaccine Market Performance
-
14.15.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Dendritic Cell Cancer Vaccine Industry Research Conclusions
-
15.2 Dendritic Cell Cancer Vaccine Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Dendritic Cell Cancer Vaccine Industry Market Size (2018-2029)
-
Figure China Dendritic Cell Cancer Vaccine Production Volume, Production Value and Growth Rate of Provenge (2018-2029)
-
Figure China Dendritic Cell Cancer Vaccine Production Volume, Production Value and Growth Rate of Tumor Antigen Presenting Cells (2018-2029)
-
Figure China Dendritic Cell Cancer Vaccine Production Volume, Production Value and Growth Rate of CreaVax (2018-2029)
-
Figure China Dendritic Cell Cancer Vaccine Sales Volume, Sales Value and Growth Rate of Adults (2018-2029)
-
Figure China Dendritic Cell Cancer Vaccine Sales Volume, Sales Value and Growth Rate of Pediatrics (2018-2029)
-
Figure North China Dendritic Cell Cancer Vaccine Market Size and Growth Rate from 2018-2029
-
Figure Central China Dendritic Cell Cancer Vaccine Market Size and Growth Rate from 2018-2029
-
Figure South China Dendritic Cell Cancer Vaccine Market Size and Growth Rate from 2018-2029
-
Figure East China Dendritic Cell Cancer Vaccine Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Dendritic Cell Cancer Vaccine Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Dendritic Cell Cancer Vaccine Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Dendritic Cell Cancer Vaccine Market Size and Growth Rate from 2018-2029
-
Figure Dendritic Cell Cancer Vaccine Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Dendritic Cell Cancer Vaccine Market Share by Type in 2018
-
Figure China Dendritic Cell Cancer Vaccine Market Share by Type in 2023
-
Figure China Dendritic Cell Cancer Vaccine Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Dendritic Cell Cancer Vaccine Production Volume and Growth Rate of Provenge (2018-2023)
-
Figure China Dendritic Cell Cancer Vaccine Production Volume and Growth Rate of Tumor Antigen Presenting Cells (2018-2023)
-
Figure China Dendritic Cell Cancer Vaccine Production Volume and Growth Rate of CreaVax (2018-2023)
-
Figure China Dendritic Cell Cancer Vaccine Market Share by Application in 2018
-
Figure China Dendritic Cell Cancer Vaccine Market Share by Application in 2023
-
Figure China Dendritic Cell Cancer Vaccine Total Market Size and Growth Rate from Consumption End
-
Figure China Dendritic Cell Cancer Vaccine Market Size and Growth Rate of Adults (2018-2023)
-
Figure China Dendritic Cell Cancer Vaccine Market Size and Growth Rate of Pediatrics (2018-2023)
-
Table China Dendritic Cell Cancer Vaccine Production Volume by Region (2018-2023)
-
Table China Dendritic Cell Cancer Vaccine Production Volume Share by Region (2018-2023)
-
Figure China Dendritic Cell Cancer Vaccine Production Volume Share by Region (2018-2023)
-
Table China Dendritic Cell Cancer Vaccine Production Value by Region (2018-2023)
-
Table China Dendritic Cell Cancer Vaccine Production Value Share by Region (2018-2023)
-
Figure China Dendritic Cell Cancer Vaccine Production Value Share by Region (2018-2023)
-
Table China Dendritic Cell Cancer Vaccine Sales Volume by Region (2018-2023)
-
Table China Dendritic Cell Cancer Vaccine Sales Volume Share by Region (2018-2023)
-
Figure China Dendritic Cell Cancer Vaccine Sales Volume Share by Region (2018-2023)
-
Table China Dendritic Cell Cancer Vaccine Sales Value by Region (2018-2023)
-
Table China Dendritic Cell Cancer Vaccine Sales Value Share by Region (2018-2023)
-
Figure China Dendritic Cell Cancer Vaccine Sales Value Share by Region (2018-2023)
-
Table North China Dendritic Cell Cancer Vaccine Production Volume by Type (2018-2023)
-
Table North China Dendritic Cell Cancer Vaccine Production Volume Share by Type (2018-2023)
-
Figure North China Dendritic Cell Cancer Vaccine Production Volume Share by Type (2018-2023)
-
Table North China Dendritic Cell Cancer Vaccine Sales Volume by Application (2018-2023)
-
Table North China Dendritic Cell Cancer Vaccine Sales Volume Share by Application (2018-2023)
-
Figure North China Dendritic Cell Cancer Vaccine Sales Volume Share by Application (2018-2023)
-
Table Central China Dendritic Cell Cancer Vaccine Production Volume by Type (2018-2023)
-
Table Central China Dendritic Cell Cancer Vaccine Production Volume Share by Type (2018-2023)
-
Figure Central China Dendritic Cell Cancer Vaccine Production Volume Share by Type (2018-2023)
-
Table Central China Dendritic Cell Cancer Vaccine Sales Volume by Application (2018-2023)
-
Table Central China Dendritic Cell Cancer Vaccine Sales Volume Share by Application (2018-2023)
-
Figure Central China Dendritic Cell Cancer Vaccine Sales Volume Share by Application (2018-2023)
-
Table South China Dendritic Cell Cancer Vaccine Production Volume by Type (2018-2023)
-
Table South China Dendritic Cell Cancer Vaccine Production Volume Share by Type (2018-2023)
-
Figure South China Dendritic Cell Cancer Vaccine Production Volume Share by Type (2018-2023)
-
Table South China Dendritic Cell Cancer Vaccine Sales Volume by Application (2018-2023)
-
Table South China Dendritic Cell Cancer Vaccine Sales Volume Share by Application (2018-2023)
-
Figure South China Dendritic Cell Cancer Vaccine Sales Volume Share by Application (2018-2023)
-
Table East China Dendritic Cell Cancer Vaccine Production Volume by Type (2018-2023)
-
Table East China Dendritic Cell Cancer Vaccine Production Volume Share by Type (2018-2023)
-
Figure East China Dendritic Cell Cancer Vaccine Production Volume Share by Type (2018-2023)
-
Table East China Dendritic Cell Cancer Vaccine Sales Volume by Application (2018-2023)
-
Table East China Dendritic Cell Cancer Vaccine Sales Volume Share by Application (2018-2023)
-
Figure East China Dendritic Cell Cancer Vaccine Sales Volume Share by Application (2018-2023)
-
Table Northeast China Dendritic Cell Cancer Vaccine Production Volume by Type (2018-2023)
-
Table Northeast China Dendritic Cell Cancer Vaccine Production Volume Share by Type (2018-2023)
-
Figure Northeast China Dendritic Cell Cancer Vaccine Production Volume Share by Type (2018-2023)
-
Table Northeast China Dendritic Cell Cancer Vaccine Sales Volume by Application (2018-2023)
-
Table Northeast China Dendritic Cell Cancer Vaccine Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Dendritic Cell Cancer Vaccine Sales Volume Share by Application (2018-2023)
-
Table Southwest China Dendritic Cell Cancer Vaccine Production Volume by Type (2018-2023)
-
Table Southwest China Dendritic Cell Cancer Vaccine Production Volume Share by Type (2018-2023)
-
Figure Southwest China Dendritic Cell Cancer Vaccine Production Volume Share by Type (2018-2023)
-
Table Southwest China Dendritic Cell Cancer Vaccine Sales Volume by Application (2018-2023)
-
Table Southwest China Dendritic Cell Cancer Vaccine Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Dendritic Cell Cancer Vaccine Sales Volume Share by Application (2018-2023)
-
Table Northwest China Dendritic Cell Cancer Vaccine Production Volume by Type (2018-2023)
-
Table Northwest China Dendritic Cell Cancer Vaccine Production Volume Share by Type (2018-2023)
-
Figure Northwest China Dendritic Cell Cancer Vaccine Production Volume Share by Type (2018-2023)
-
Table Northwest China Dendritic Cell Cancer Vaccine Sales Volume by Application (2018-2023)
-
Table Northwest China Dendritic Cell Cancer Vaccine Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Dendritic Cell Cancer Vaccine Sales Volume Share by Application (2018-2023)
-
Table DanDrit Biotech Company Profile
-
Table DanDrit Biotech Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
Table DCPrime Company Profile
-
Table DCPrime Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
Table Bellicum Pharmaceuticals Company Profile
-
Table Bellicum Pharmaceuticals Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
Table Medigene Company Profile
-
Table Medigene Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
Table Argos Therapeutics Company Profile
-
Table Argos Therapeutics Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
Table Sanpower Corporation (Dendreon) Company Profile
-
Table Sanpower Corporation (Dendreon) Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
Table Vaxil Bio Company Profile
-
Table Vaxil Bio Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
Table Elios Therapeutics Company Profile
-
Table Elios Therapeutics Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
Table Tella Company Profile
-
Table Tella Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
Table Batavia Bioservices Company Profile
-
Table Batavia Bioservices Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
Table Kiromic Company Profile
-
Table Kiromic Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
Table Northwest Biotherapeutics Company Profile
-
Table Northwest Biotherapeutics Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
Table Immunicum Company Profile
-
Table Immunicum Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
Table Creagene Company Profile
-
Table Creagene Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
Table Activarti Company Profile
-
Table Activarti Dendritic Cell Cancer Vaccine Revenue, Price and Gross (2018-2023)
-
